5 healthcare fights Democrats could take on after midterms sweep
Democrats’ victories in the midterm elections could impact healthcare, from how much people pay for health insurance and prescription drugs to what coverage is available.
Health
Latest
How healthy are your muscles?
Body mechanics experts say muscle health is linked to our longevity and how well we fight off disease.
WHO approves trials for two new Ebola vaccines
Two new vaccines were designed for the Bundibugyo virus that has killed more than 5,300 in the DR Congo.
Some cats are shy, just like human infants
Some cats display a complex mixture of fear and curiosity, which is similar to shyness observed in human infants, according to a study published Nov. 4, 2026, in the journal PLOS One by Madoka Hattori at Kyoto University, Japan, and colleagues.
STAT+: Democratic doctors and scientists ride the blue wave
The clinicians and researchers who will take office are ready to tackle the U.S. health care system.
Hospital stocks rally while drugmakers brace for scrutiny. Here’s what the Democratic wave means for healthcare.
The Democratic victory in the midterm elections could be a huge boon to the nation’s largest hospitals.
STAT+: Where does MAHA go from here? Three possible futures
Republican losses leave Robert F. Kennedy Jr.’s MAHA movement with three possible futures.
STAT+: CVS Health to split, reversing years of deal-making to combine pharmacies and insurance
CVS Health’s decision to split comes amid federal and state scrutiny over vertical integration.
The DEA banned a drug some opioid users called a miracle
Researchers say the Schedule I ban could kill studies of a promising opioid treatment.
STAT+: Ultragenyx cuts staff after another study fails
Ultragenyx announced that it's laying off about 20% of its staff as it ends development of two rare disease drugs.
STAT+: Pharmalittle: We’re reading about CVS plans to split up, FDA inspections in India and China and more
The Trump administration will survey key components of pharmaceutical production in order to identify domestic supply chain vulnerabilities.
STAT+: Sens. Wyden and Sanders, backers of Medicare for All, set to take charge of key committees
The Democratic flip of the Senate is expected to put two Democrats who support Medicare for All in charge of key committees.
STAT+: Former Madrigal Pharmaceuticals executive alleges coverup of safety issues tied to its drug
A top former executive at Madrigal Pharmaceuticals has filed a lawsuit in federal court alleging a coverup of drug safety issues.
CVS Health plans to split in two. Here’s what is driving the massive healthcare breakup.
The healthcare giant surprised analysts with the decision to separate its business.
Top health takeaways from the midterm elections
Democrats gained control of both chambers of Congress, and doctors and scientists won key seats. Here are the top health takeaways from the midterms.
CVS to Split off Pharmacy Business, Ending the Healthcare Conglomerate Era
In a breakup planned for 2028, CVS Health intends to split off its pharmacies into a new company, while keeping together its businesses in insurance and pharmacy benefits.
CVS to split off drugstore business in major breakup of healthcare giant
The move would reverse the company's $78 billion acquisition of Aetna, and dismantle the vertically integrated healthcare conglomerate it created in 2018.
Opinion: I moved to Europe for free health care. I miss my patient portal
“To be honest, in Malta, I pay for medical care all the time. I just pay differently,” writes Mariska Breland.
As Pressure Mounts On Vertical Integration, CVS Health To Split Into Two Companies
CVS Health will split into two companies, putting the more than 9,000 drugstores under one business and its Aetna health insurance and pharmacy benefit operations into another.
Gene editing could replace a lifetime of medication, but there's a catch
A single gene-editing treatment could someday protect against heart disease, high cholesterol, and other common conditions for decades, potentially replacing lifelong medications. But scientists warn that permanently altering genes introduces risks that could take years to emerge, making long-term safety a critical challenge.
Scientists trick cancer cells into making the drugs that kill them
Scientists have developed a promising new cancer-fighting strategy that uses carbon monoxide naturally produced by tumor cells to manufacture powerful drugs inside the cancer cells themselves. Early laboratory experiments suggest the technique could selectively attack cancer while sparing healthy cells, potentially paving the way for safer chemotherapy alternatives.